Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The AutoloGel™ Post-Market Surveillance (TAPS) Program

NCT00762138 is registered in ClinicalTrials.gov with Cytomedix as lead sponsor.

NCT NCT00762138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00762138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Lead sponsor
Cytomedix
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2008
Completion date
June 30, 2012
Enrollment
131 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcers, leg ulcers, pressure ulcers, wounds